NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report

M. Barreiro-de Acosta, S. Ouburg, S.A. Morré, J.B.A. Crusius, A. Lorenzo, J. Potel, A.S. Pena, J.E. Dominguez-Munoz

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Scopus)
Original languageEnglish
Pages (from-to)591-595
JournalRevista Española de Enfermedades Digestivas
Issue number10
Publication statusPublished - 2010

Cite this